STOCK TITAN

Cantaloupe, Inc. (CTLP) Financials

CTLP
Trailing 12 months to March 31, 2026
Revenue $320.8M +9.6% YoY
Net Income $3.7M -93.9% YoY
EPS (Diluted) $0.04 -94.9% YoY
Free Cash Flow $15.4M +105.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CTLP SEC filings page.

Cantaloupe, Inc. (CTLP) reported $320.8M in revenue over the twelve months to Mar 31, 2026, up 9.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CTLP FY2025

Operating profitability is improving, but FY2025 headline earnings were shaped by a large tax benefit and substantial reinvestment.

FY2025 net income reached $64.5M, including a $42.4M tax benefit, while operating cash flow was only $20.3M; the gap means reported earnings overstate the period’s recurring operating performance. Capital spending of $17.0M reduced free cash flow to $3.3M, so accounting profit was not equally available as cash.

Gross margin reached 40.9% in FY2025 from 32.4% in FY2021, showing a structurally better revenue-cost relationship. Revenue reached $302.5M, and operating margin reached 7.4% after being negative in FY2021; scale and margin improvement arrived together, consistent with better operating economics.

Assets grew to $381.9M while liabilities fell to $128.1M by FY2025, strengthening the company’s equity cushion. Yet the combination of high reinvestment and limited free cash flow shows that improved profitability still requires meaningful cash investment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 56 / 100
Financial Health Score 56/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cantaloupe, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
46

Cantaloupe, Inc. has an operating margin of 7.4%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 46/100, indicating healthy but not exceptional operating efficiency. This is up from 5.3% the prior year.

Growth
68

Cantaloupe, Inc.'s revenue grew 12.6% year-over-year to $302.5M, a solid pace of expansion. This earns a growth score of 68/100.

Leverage
93

Cantaloupe, Inc. carries a low D/E ratio of 0.15, meaning only $0.15 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
55

Cantaloupe, Inc.'s current ratio of 1.86 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
32

While Cantaloupe, Inc. generated $20.3M in operating cash flow, capex of $17.0M consumed most of it, leaving $3.3M in free cash flow. This results in a low score of 32/100, reflecting heavy capital investment rather than weak cash generation.

Returns
43

Cantaloupe, Inc.'s ROE of 25.7% shows moderate profitability relative to equity, earning a score of 43/100. This is up from 6.6% the prior year.

Altman Z-Score Safe
4.21

Cantaloupe, Inc. scores 4.21, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($825.8M) relative to total liabilities ($128.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Cantaloupe, Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality
0.32x

For every $1 of reported earnings, Cantaloupe, Inc. generates $0.32 in operating cash flow ($20.3M OCF vs $64.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage Safe
8.06x

Cantaloupe, Inc. earns $8.06 in operating income for every $1 of interest expense ($22.3M vs $2.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$78.7M
YoY+4.3%
QoQ0.0%
5Y CAGR+13.0%
10Y CAGR+14.5%

Cantaloupe, Inc. generated $78.7M in revenue in Q3 2026. This represents an increase of 4.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

EBITDA
$3.5M
YoY-73.4%
QoQ-39.5%

Cantaloupe, Inc.'s EBITDA was $3.5M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 73.4% from the same quarter a year earlier. Against the prior quarter it is down 39.5%.

Net Income
-$2.2M
YoY-104.4%
QoQ-2982.9%

Cantaloupe, Inc. reported -$2.2M in net income in Q3 2026. This represents a decrease of 104.4% from the same quarter a year earlier. Against the prior quarter it is down 2982.9%.

EPS (Diluted)
-$0.03
YoY-104.6%

Cantaloupe, Inc. earned -$0.03 per diluted share (EPS) in Q3 2026. This represents a decrease of 104.6% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow
$8.1M
YoY-56.2%
QoQ+1425.2%
5Y CAGR-0.1%
10Y CAGR+6.9%

Cantaloupe, Inc. generated $8.1M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 56.2% from the same quarter a year earlier. Against the prior quarter it is up 1425.2%.

Cash & Debt
$60.4M
YoY+30.4%
QoQ+14.0%
5Y CAGR-7.4%
10Y CAGR+15.0%

Cantaloupe, Inc. held $60.4M in cash against $35.1M in long-term debt as of Q3 2026.

Shares Outstanding
74M
YoY+0.9%
QoQ0.0%
5Y CAGR+0.7%
10Y CAGR+7.2%

Cantaloupe, Inc. had 74M shares outstanding in Q3 2026. This represents an increase of 0.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
38.7%
YoY-2.9pp
QoQ-0.1pp

Cantaloupe, Inc.'s gross margin was 38.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Operating Margin
-1.0%
YoY-10.1pp
QoQ-3.0pp

Cantaloupe, Inc.'s operating margin was -1.0% in Q3 2026, reflecting core business profitability. This is down 10.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.0 percentage points.

Net Margin
-2.7%
YoY-67.9pp
QoQ-2.6pp

Cantaloupe, Inc.'s net profit margin was -2.7% in Q3 2026, showing the share of revenue converted to profit. This is down 67.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.6 percentage points.

Return on Equity
-0.9%
YoY-21.3pp
QoQ-0.8pp

Cantaloupe, Inc.'s ROE was -0.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 21.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Capital Allocation

Capital Expenditures
$3.8M
YoY-1.8%
QoQ+0.1%
5Y CAGR+64.7%
10Y CAGR+36.8%

Cantaloupe, Inc. invested $3.8M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 1.8% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

CTLP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTLP quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$78.7M+4.3%$78.7M+6.8%$80.9M+14.1%$82.6M+13.6%$75.4M+11.1%$73.7M+12.8%$70.8M+13.0%$72.7M+13.2%
Cost of Revenue$48.3M+9.5%$48.2M+12.0%$47.3M+12.8%$49.7M+9.0%$44.1M+7.5%$43.0M+4.8%$42.0M+9.5%$45.6M+18.5%
Gross Profit$30.4M-2.9%$30.5M-0.6%$33.5M+16.2%$32.9M+21.4%$31.4M+16.6%$30.7M+26.3%$28.9M+18.6%$27.1M+5.3%
SG&A Expenses$10.7M+26.2%$10.3M-8.3%$9.4M-21.6%$12.4M+4.5%$8.5M-0.9%$11.2M+7.0%$11.9M+14.3%$11.9M+1.3%
Operating Income-$767K-111.1%$1.6M-73.9%$1.6M-60.4%$5.2M+45.9%$6.9M+60.7%$6.2M+71.9%$4.1M+49.1%$3.5M+2.5%
EBITDA$3.5M-73.4%$5.8M-38.6%$5.4M-20.0%$8.6M+40.8%$13.3M+95.5%$9.5M+50.8%$6.8M+23.2%$6.1M+1.5%
Interest Expense$155K+297.4%$837K-15.7%$914K-7.8%$746K$39K$993K-0.9%$991K-10.5%N/A
Income Tax$1.5M+103.6%$1.1M+190.4%$1.9M+991.5%-$1.0M-238.0%-$41.9M-49985.7%$395K+387.7%$177K+118.5%$739K+1196.5%
Net Income-$2.2M-104.4%-$70K-101.4%-$919K-125.7%$6.8M+209.7%$49.2M+955.8%$5.0M+59.2%$3.6M+78.0%$2.2M-22.1%
EPS (Basic)-$0.03-104.5%$0.00-100.0%-$0.02-150.0%$0.09+200.0%$0.67+1016.7%$0.07+75.0%$0.04+100.0%$0.03-25.0%
EPS (Diluted)-$0.03-104.6%$0.00-100.0%-$0.02$0.09+200.0%$0.65+983.3%$0.07+75.0%$0.04+100.0%$0.03-25.0%
Diluted Shares (Avg)74M-1.1%74M-1.1%74MN/A75M+0.9%75M+1.1%74M-0.5%N/A

Not reported in any period shown, so not listed: R&D Expenses.

CTLP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTLP quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$389.0M+5.0%$381.9M+26.0%$389.5M+24.8%$381.9M+13.8%$370.5M+15.8%$303.0M+0.2%$312.1M+3.8%$335.6M+15.9%
Current Assets$171.4M+18.0%$159.9M+36.7%$163.5M+32.1%$152.9M-3.1%$145.2M+0.1%$117.0M-10.7%$123.7M-7.6%$157.8M+27.9%
Cash & Equivalents$60.4M+30.4%$53.0M+91.4%$55.0M+66.0%$51.1M-13.2%$46.3M-7.7%$27.7M-36.3%$33.1M-39.3%$58.9M+15.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$50.8M+10.0%$50.7M+13.4%$47.7M+6.9%$45.7M+12.0%$46.2M+23.7%$44.7M+28.5%$44.6M+38.4%$40.8M+28.0%
Accounts Receivable$39.8M+17.4%$36.8M+26.5%$41.9M+28.8%$37.9M-13.5%$33.9M-21.7%$29.1M-27.6%$32.5M-12.2%$43.8M+45.4%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$102.9M+0.1%$103.1M+0.8%$103.1M+0.4%$103.2M+8.8%$102.8M+9.4%$102.3M+10.1%$102.7M+11.2%$94.9M+3.1%
Total Liabilities$135.9M+6.9%$126.8M+15.0%$135.0M+9.6%$128.1M-15.2%$127.1M-8.1%$110.2M-12.9%$123.2M-4.6%$151.1M+23.8%
Current Liabilities$93.4M+15.3%$83.2M+28.4%$90.1M+16.8%$82.4M-22.2%$81.0M-12.3%$64.8M-19.0%$77.2M-11.6%$105.9M+29.6%
Non-Current Liabilities$42.5M-8.0%$43.5M-4.1%$44.8M-2.6%$45.7M+1.1%$46.1M+0.1%$45.4M-2.6%$46.0M+10.2%$45.2M+12.1%
Long-Term Debt$35.1M-5.8%$35.8M+0.7%$36.4M+1.2%$36.7M+1.3%$37.2M+1.6%$35.6M-3.9%$35.9M-3.6%$36.3M-3.4%
Total Equity$250.4M+4.0%$252.5M+32.8%$251.8M+35.2%$251.0M+38.1%$240.7M+34.6%$190.1M+9.8%$186.2M+10.3%$181.7M+10.2%
Retained Earnings-$239.1M+1.5%-$236.9M+18.8%-$236.8M+20.2%-$235.9M+21.5%-$242.8M+19.8%-$291.9M+5.0%-$296.9M+4.4%-$300.5M+3.8%

CTLP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTLP quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$11.9M-46.9%$3.1M+503.4%$7.0M+158.0%$9.4M-33.9%$22.4M+52.3%$522K+106.6%-$12.0M-279.3%$14.3M+69.4%
Depreciation & Amortization$4.3M-32.4%$4.2M+26.0%$3.8M+42.0%$3.5M+33.8%$6.4M+155.4%$3.4M+23.0%$2.7M-2.7%$2.6M+0.2%
Capital Expenditures$3.8M-1.8%$3.8M-12.3%$3.4M-9.4%$5.1M-11.7%$3.8M+17.6%$4.3M+43.2%$3.8M+30.0%$5.8M+63.8%
Free Cash Flow$8.1M-56.2%-$614K+83.7%$3.5M+122.4%$4.3M-49.0%$18.6M+62.2%-$3.8M+65.5%-$15.8M-517.5%$8.5M+73.5%
Investing Cash Flow-$3.8M+27.7%-$3.8M+12.3%-$3.4M+74.7%-$5.1M-8.0%-$5.2M+35.0%-$4.3M-43.2%-$13.6M-364.7%-$4.7M-39.5%
Financing Cash Flow-$725K-242.4%-$1.4M-193.1%$315K+170.0%$459K+160.0%$509K+2894.1%-$476K-146.6%-$450K-284.6%-$765K+3.4%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

CTLP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CTLP quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin38.7%-2.9pp38.8%-2.9pp41.4%+0.7pp39.8%+2.5pp41.6%+2.0pp41.7%+4.5pp40.7%+1.9pp37.3%-2.8pp
Operating Margin-1.0%-10.1pp2.0%-6.3pp2.0%-3.8pp6.3%+1.4pp9.2%+2.8pp8.4%+2.9pp5.8%+1.4pp4.9%-0.5pp
Net Margin-2.7%-67.9pp-0.1%-6.8pp-1.1%-6.2pp8.3%+5.2pp65.2%+58.3pp6.8%+2.0pp5.0%+1.8pp3.0%-1.4pp
Return on Equity-0.9%-21.3pp0.0%-2.7pp-0.4%-2.3pp2.7%+1.5pp20.4%+17.8pp2.6%+0.8pp1.9%+0.7pp1.2%-0.5pp
Return on Assets-0.5%-13.8pp0.0%-1.7pp-0.2%-1.4pp1.8%+1.1pp13.3%+11.8pp1.6%+0.6pp1.1%+0.5pp0.7%-0.3pp
Current Ratio1.830.0x1.92+0.1x1.81+0.2x1.86+0.4x1.79+0.2x1.81+0.2x1.60+0.1x1.490.0x
Debt-to-Equity0.140.0x0.140.0x0.140.0x0.15-0.1x0.15-0.1x0.190.0x0.190.0x0.200.0x
Asset Turnover0.200.0x0.210.0x0.210.0x0.220.0x0.200.0x0.240.0x0.230.0x0.220.0x
FCF Margin10.3%-14.3pp-0.8%+4.3pp4.4%+26.7pp5.3%-6.4pp24.6%+7.8pp-5.1%+11.6pp-22.3%-28.4pp11.7%+4.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Cantaloupe, Inc. CTLP FY2025 $302.5M $64.5M 21.3% $825.8M 56/100
Paysafe Limited PSFE FY2025 $1.7B -$182.5M -10.6% $299.7M 39/100
Sabre Corporation SABR FY2025 $2.8B $524.6M 18.9% $778.9M 29/100
Aeva Technologies, Inc. AEVA FY2025 $18.1M -$145.0M N/A $954.3M 65/100
Exodus Movement, Inc. EXOD FY2025 $121.6M -$11.4M -9.3% $190.6M 48/100
PowerFleet, Inc. AIOT FY2026 $443.8M $20.6M 4.6% $354.4M 39/100

Frequently Asked Questions

What is Cantaloupe, Inc.'s annual revenue?

Cantaloupe, Inc. (CTLP) reported $302.5M in total revenue for fiscal year 2025. This represents a 12.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cantaloupe, Inc.'s revenue growing?

Cantaloupe, Inc. (CTLP) revenue grew by 12.6% year-over-year, from $268.6M to $302.5M in fiscal year 2025.

Is Cantaloupe, Inc. profitable?

Yes, Cantaloupe, Inc. (CTLP) reported a net income of $64.5M in fiscal year 2025, with a net profit margin of 21.3%.

Cantaloupe, Inc. (CTLP) reported diluted earnings per share of $0.86 for fiscal year 2025. This represents a 473.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cantaloupe, Inc. (CTLP) had EBITDA of $38.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Cantaloupe, Inc. (CTLP) had $51.1M in cash and equivalents against $36.7M in long-term debt.

Cantaloupe, Inc. (CTLP) had a gross margin of 40.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Cantaloupe, Inc. (CTLP) had an operating margin of 7.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cantaloupe, Inc. (CTLP) had a net profit margin of 21.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Cantaloupe, Inc. (CTLP) has a return on equity of 25.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cantaloupe, Inc. (CTLP) generated $3.3M in free cash flow during fiscal year 2025. This represents a -74.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cantaloupe, Inc. (CTLP) generated $20.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cantaloupe, Inc. (CTLP) had $381.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Cantaloupe, Inc. (CTLP) invested $17.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Cantaloupe, Inc. (CTLP) invested $2.9M in research and development during fiscal year 2025.

Cantaloupe, Inc. (CTLP) had 73M shares outstanding as of fiscal year 2025.

Cantaloupe, Inc. (CTLP) had a current ratio of 1.86 as of fiscal year 2025, which is generally considered healthy.

Cantaloupe, Inc. (CTLP) had a debt-to-equity ratio of 0.15 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cantaloupe, Inc. (CTLP) had a return on assets of 16.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cantaloupe, Inc. (CTLP) has an Altman Z-Score of 4.21, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Cantaloupe, Inc. (CTLP) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cantaloupe, Inc. (CTLP) has an earnings quality ratio of 0.32x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cantaloupe, Inc. (CTLP) has an interest coverage ratio of 8.06x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Cantaloupe, Inc. (CTLP) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top